Asosiy kontentga oʻtish
AkademScholar

Kashfiyot

Xizmatlar

Identifikatsiya

Ishlab chiquvchilar uchun

Ekotizim

Muassasalar

National Medical Research Center of Cardiology

Nom variantlari: National Medical Research Center of Cardiology of the Ministry of Healthcare of the Russian Federation · Федеральное государственное бюджетное учреждение НАЦИОНАЛЬНЫЙ МЕДИЦИНСКИЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР КАРДИОЛОГИИ Министерства здравоохранения Российской Федерации

Davlat:
RU
ROR:
https://ror.org/04f17cx55
3
h-indeks
42
Iqtiboslar
32
Asarlar
60
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
0134503581020062018201920202021202220232024202520262006: Nashrlar 1, Iqtiboslar 02018: Nashrlar 3, Iqtiboslar 02019: Nashrlar 5, Iqtiboslar 02020: Nashrlar 2, Iqtiboslar 22021: Nashrlar 4, Iqtiboslar 22022: Nashrlar 4, Iqtiboslar 92023: Nashrlar 5, Iqtiboslar 92024: Nashrlar 3, Iqtiboslar 72025: Nashrlar 3, Iqtiboslar 82026: Nashrlar 2, Iqtiboslar 5

Iqtibos tarixi

03581020062018201920202021202220232024202520262006: Iqtiboslar 02018: Iqtiboslar 02019: Iqtiboslar 02020: Iqtiboslar 22021: Iqtiboslar 22022: Iqtiboslar 92023: Iqtiboslar 92024: Iqtiboslar 72025: Iqtiboslar 82026: Iqtiboslar 5

Nashr tarixi

0134520062018201920202021202220232024202520262006: Nashrlar 12018: Nashrlar 32019: Nashrlar 52020: Nashrlar 22021: Nashrlar 42022: Nashrlar 42023: Nashrlar 52024: Nashrlar 32025: Nashrlar 32026: Nashrlar 2

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

0134520062018201920202021202220232024202520262006: h-indeks 02018: h-indeks 02019: h-indeks 02020: h-indeks 12021: h-indeks 12022: h-indeks 22023: h-indeks 22024: h-indeks 32025: h-indeks 32026: h-indeks 3

Eng koʻp iqtibos qilingan asarlar

  1. Clinical features of post-COVID-19 period. Results of the international register “Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)”. Data from 6-month follow-up20213 iqtibos
  2. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)20182 iqtibos
  3. Methodology and implementation of the WHO European Childhood Obesity Surveillance Initiative (COSI)20211 iqtibos
  4. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)20211 iqtibos
  5. Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity20231 iqtibos
  6. Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry20251 iqtibos
  7. The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries20231 iqtibos
  8. Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)20220 iqtibos
  9. Cost-effectiveness analysis of custom-made and serial acetabular components in revision hip arthroplasty20220 iqtibos
  10. Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)20220 iqtibos